Bluebird could be on the way to a cure for sickle cell disease
December 11, 2017 at 13:43 PM EST
CEO Nick Leschly said Bluebird is cautious about calling its drugs cures, though it's "definitely a potential."
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|